RightFit
RecruitingNot applicable

Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
18 Years to 39 Years
Sex
All sexes
Healthy volunteers
Not accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

Not stated in the study description — ask the study team about visits and procedures.

Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This study tests a digital health program called AYA STEPS for teen and young adult cancer survivors. It aims to help them manage symptoms and take part in recommended follow-up care.

The purpose of this study is to determine the effectiveness of a digital health program called AYA STEPS, which is designed to help adolescent and young adult (AYA) cancer survivors manage symptoms and engage in recommended follow-up care.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • Had stage I–III breast cancer, colorectal cancer (colon or rectum), sarcoma (bone or soft tissue), or Hodgkin or non-Hodgkin lymphoma (immune system cancers); or stage I–II testicular cancer.
  • Had treatment meant to cure the cancer and have been off treatment for at least 3 months. Hormone therapy or targeted cancer pills to keep cancer from returning or growing are allowed.
  • Were diagnosed with cancer 1 to 5 years ago.
  • Can speak and read English.
  • Can understand the study and agree to take part.

Who can't join

  • Have moderate or severe problems with thinking or memory.
  • Have a severe, untreated mental illness, such as schizophrenia or a substance use disorder, that would make it hard to understand and agree to the study or take part.

Simplified for readability. The official criteria below are what the study team uses.

Official eligibility criteria

Inclusion Criteria: * Diagnosed with one of the following cancers: 1) stage I-III breast cancer; 2) stage I-III colorectal cancer; 3) stage I-III sarcoma; 4) stage I-III Hodgkin or non-Hodgkin lymphoma; or 5) stage I-II testicular cancer * treated with curative intent and off therapy (with the exception of endocrine/hormonal therapy or oral targeted therapies used to prevent disease recurrence or progression) for the last three months * 1 to 5 years post-diagnosis * Able to speak and read English * Able to give informed consent Exclusion Criteria: * moderate or severe cognitive impairment * severe untreated mental illness (e.g., schizophrenia, substance use disorder) that would interfere with providing meaningful consent/study participation

Study sites (1)

NC